AGP Executive Report
Last update: 7 hours agoHemp Rules: Illinois will restrict intoxicating hemp-derived THC sales to licensed dispensaries from Nov. 12, putting cafés and retailers at risk. A wider federal ban is due Dec. 11, though hemp businesses hope election results could prompt a change. Industry Shakeout: Cann Group says Australian medicinal cannabis has more capacity than demand can support and is discussing shared resources with competitors. Elixinol is exiting the U.S. to focus on Australian wellness brands; losses narrowed, but its latest report still flags funding concerns. M&A and Market Access: Organigram is acquiring Aurora Cannabis, while U.S. regulators have issued federal registrations to hundreds of state-licensed medical cannabis dispensaries ahead of a Nov. 29 supply-chain deadline. CBD Regulation: An EU court ruled that CBD foods without authorization cannot carry an organic label, adding a hurdle for brands selling cannabidiol products in Europe. Product Development: MediPharm Labs says a European regulatory milestone supports plans to commercialize its metered-dose cannabis inhaler.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
